Quantifying the rate and predictors of occult lymph node involvement in patients with clinically node-negative non-small cell lung cancer

References

• National Comprehensive Cancer Network. Non-small cell lung cancer. Version 5; 2021 [cited 2021 June 18]. https://www.nccn.org/professionals/physician_gls/pdf/nscl.pdf.
   Google Scholar
• Wu Y, Li P, Zhang H, et al. Diagnostic value of fluorine 18 fluorodeoxyglucose positron emission tomography/computed tomography for the detection of metastases in non-small-cell lung cancer patients. Int J Cancer. 2013;132(2):E37–47.
   PubMed Web of Science ®Google Scholar
• Silvestri GA, Gonzalez AV, Jantz MA, et al. Methods for staging non-small cell lung cancer: diagnosis and management of lung cancer, 3rd ed: American college of chest physicians evidence-based clinical practice guidelines. Chest. 2013;143(5 Suppl):e211S–e250s.
   PubMed Web of Science ®Google Scholar
• Oda M, Watanabe Y, Shimizu J, et al. Extent of mediastinal node metastasis in clinical stage I non-small-cell lung cancer: the role of systematic nodal dissection. Lung Cancer. 1998;22:23–30.
   PubMed Web of Science ®Google Scholar
• Seok Y, Yang HC, Kim TJ, et al. Frequency of lymph node metastasis according to the size of tumors in resected pulmonary adenocarcinoma with a size of 30 mm or smaller. J Thorac Oncol. 2014;9(6):818–824.
   PubMed Web of Science ®Google Scholar
• Ding N, Mao Y, Gao S, et al. Predictors of lymph node metastasis and possible selective lymph node dissection in clinical stage IA non-small cell lung cancer. J Thorac Dis. 2018;10(7):4061–4068.
   PubMed Web of Science ®Google Scholar
• Ichinose Y, Yano T, Yokoyama H, et al. The correlation between tumor size and lymphatic vessel invasion in resected peripheral stage I non-small-cell lung cancer: a potential risk of limited resection. J Thorac Cardiovasc Surg. 1994;108(4):684–686.
   PubMed Web of Science ®Google Scholar
• Bilimoria K, Stewart A, Winchester D, et al. The national cancer data base: a powerful initiative to improve cancer care in the United States. Ann Surg Oncol. 2008;15(3):683–690.
   PubMed Web of Science ®Google Scholar
• Verma V, McMillan MT, Grover S, et al. Stereotactic body radiation therapy and the influence of chemotherapy on overall survival for large (≥5 centimeter) non-small cell lung cancer. Int J Radiat Oncol Biol Phys. 2017;97(1):146–154.
   Google Scholar
• Kann BH, Miccio JA, Stahl JM, et al. Stereotactic body radiotherapy with adjuvant systemic therapy for early-stage non-small cell lung carcinoma: a multi-institutional analysis. Radiother Oncol. 2019;132:188–196.
   PubMed Web of Science ®Google Scholar
• Brooks ED, Sun B, Feng L, et al. Association of long-term outcomes and survival with multidisciplinary salvage treatment for local and regional recurrence after stereotactic ablative radiotherapy for early-stage lung cancer. JAMA Netw Open. 2018;1(4):e181390.
   PubMed Web of Science ®Google Scholar
• Brooks ED, Verma V, Senan S, et al.; International Association for the Study of Lung Cancer Advanced Radiation Technology Committee. Salvage therapy for locoregional recurrence after stereotactic ablative radiotherapy for Early-Stage NSCLC. J Thorac Oncol. 2020;15(2):176–189.
   PubMed Web of Science ®Google Scholar
• Gu Y, She Y, Xie D, et al. A texture analysis–based prediction model for lymph node metastasis in stage IA lung adenocarcinoma. Ann Thorac Surg. 2018;106(1):214–220.
   PubMed Web of Science ®Google Scholar
• Ketchedjian A, Daly BDT, Fernando HC, et al. Location as an important predictor of lymph node involvement for pulmonary adenocarcinoma. J Thorac Cardiovasc Surg. 2006;132(3):544–548.
   PubMed Web of Science ®Google Scholar
• Higashi K, Ito K, Hiramatsu Y, et al. 18F-FDG uptake by primary tumor as a predictor of intratumoral lymphatic vessel invasion and lymph node involvement in non-small cell lung cancer: analysis of a multicenter study. J Nuc Med. 2005;46:267–273.
   PubMed Web of Science ®Google Scholar
• Suzuki K, Nagai K, Yoshida J, et al. Predictors of lymph node and intrapulmonary metastasis in clinical stage IA non–small cell lung carcinoma. Ann Thorac Surg. 2001;72(2):352–356.
   PubMed Web of Science ®Google Scholar
• Matsuguma H, Yokoi K, Anraku M, et al. Proportion of ground-glass opacity on high-resolution computed tomography in clinical T1 N0 M0 adenocarcinoma of the lung: a predictor of lymph node metastasis. Surgery. 2002;124:278–284.
   Web of Science ®Google Scholar
• Sun W, Yang X, Liu Y, et al. Primary tumor location is a useful predictor for lymph node metastasis and prognosis in lung adenocarcinoma. Clin Lung Cancer. 2017;18(1):e49–e55.
   PubMed Web of Science ®Google Scholar